Provided By GlobeNewswire
Last update: Jul 9, 2025
FLORHAM PARK, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company focused on addressing age-related and degenerative diseases, announced today that it entered into a strategic partnership with Fountain Life, a global leader in science-backed longevity and preventative health company, to supply stem cell therapy products manufactured and distributed by Celularity.
Read more at globenewswire.comNASDAQ:CELUW (10/24/2025, 4:00:00 PM)
0.0298
+0.01 (+45.37%)
NASDAQ:CELU (10/24/2025, 8:13:57 PM)
2.07
+0.08 (+4.02%)
Find more stocks in the Stock Screener


